KLK11 and ovarian carcinoma: An immunofluorometric assay study demonstrated that KLK11 expression in ovarian cancer tissues is a marker of favorable prognosis, since patients with KLK-positive tumors exhibit a longer progression-free survival (PFS) and overall survival (OS) [10].